Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph S Ross

Showing results (61-70 of 800) with videos related to

Pageof 80
Sort By:
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|September 28, 2019
Biomarkers as Surrogate Endpoints: Ongoing Opportunities for ValidationAudrey D Zhang, Joseph S Ross
JAMA|January 30, 2014
Innovation, risk, and patient empowerment: the FDA-mandated withdrawal of 23andMe's Personal Genome ServiceNicholas S Downing, Joseph S Ross
JAMA|June 19, 2014
Withdrawal of Personal Genome Service--replyNicholas S Downing, Joseph S Ross
JAMA|November 7, 2024
Industry Payments to Physicians by Competing Manufacturers Within Novel Therapeutic ClassesQ Wilton Sun, Joseph S Ross
The New England Journal of Medicine|October 24, 2019
Modernizing the FDA's 510(k) PathwayVinay K Rathi, Joseph S Ross
Journal of General Internal Medicine|March 30, 2013
Direct-to-consumer television advertising: time to turn off the tube?Joseph S Ross, Richard L Kravitz
European Heart Journal|June 7, 2012
Through the looking glass: evaluating the dissemination of research in cardiologyJoseph S Ross, Brahmajee K Nallamothu
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Mis-SHAPEing public health policyErica S Spatz, Joseph S Ross
Annals of Internal Medicine|December 4, 2018
Weighing the Harms and Benefits of Using Statins for Primary Prevention: Raising the Risk ThresholdIlana B Richman, Joseph S Ross
AMA Journal of Ethics|December 25, 2015
US Federal Government Efforts to Improve Clinical Trial Transparency with Expanded Trial Registries and Open Data SharingDaniel L Shaw, Joseph S Ross
Pageof 80

Showing results (61-70 of 800) with videos related to

Sort By:
Pageof 80
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|September 28, 2019
Biomarkers as Surrogate Endpoints: Ongoing Opportunities for ValidationAudrey D Zhang, Joseph S Ross
JAMA|January 30, 2014
Innovation, risk, and patient empowerment: the FDA-mandated withdrawal of 23andMe's Personal Genome ServiceNicholas S Downing, Joseph S Ross
JAMA|June 19, 2014
Withdrawal of Personal Genome Service--replyNicholas S Downing, Joseph S Ross
JAMA|November 7, 2024
Industry Payments to Physicians by Competing Manufacturers Within Novel Therapeutic ClassesQ Wilton Sun, Joseph S Ross
The New England Journal of Medicine|October 24, 2019
Modernizing the FDA's 510(k) PathwayVinay K Rathi, Joseph S Ross
Journal of General Internal Medicine|March 30, 2013
Direct-to-consumer television advertising: time to turn off the tube?Joseph S Ross, Richard L Kravitz
European Heart Journal|June 7, 2012
Through the looking glass: evaluating the dissemination of research in cardiologyJoseph S Ross, Brahmajee K Nallamothu
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Mis-SHAPEing public health policyErica S Spatz, Joseph S Ross
Annals of Internal Medicine|December 4, 2018
Weighing the Harms and Benefits of Using Statins for Primary Prevention: Raising the Risk ThresholdIlana B Richman, Joseph S Ross
AMA Journal of Ethics|December 25, 2015
US Federal Government Efforts to Improve Clinical Trial Transparency with Expanded Trial Registries and Open Data SharingDaniel L Shaw, Joseph S Ross
Pageof 80